416
Participants
Start Date
June 20, 2023
Primary Completion Date
September 30, 2027
Study Completion Date
December 31, 2027
MRD
ctDNA MRD test
Hadassah University Hospital - Mount Scopus, Jerusalem
Istituto Clinico Humanitas, Rozzano
Istituto Nazionale Tumori - Fondazione G Pascale, Napoli
ASST Grande Ospedale Metropolitano Niguarda, Milan
Hospital Universitario La Paz, Madrid
Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid
Tel Aviv Sourasky Medical Center, Tel Aviv Yaffo
HaEmek Medical Center, Afula
Hillel Yaffe Medical Center, Hadera
Kagawa University Hospital, Kita-gun
Soroka University Medical Center, Beersheba
Shaare Zedek Medical Center Jerusalem, Jerusalem
National Cancer Center Hospital East, Kashiwa
Hokkaido Cancer Center, Sapporo
Churchill Hospital, Headington
Edinburgh Cancer Centre, Edinburgh
Queen Elizabeth Hospital Birmingham, Birmingham
Worcestershire Royal Hospital, Worcester
Ipswich Hospital, Ipswich
Kidderminster Hospital and Treatment Centre, Kidderminster
Alexandra Hospital, Redditch
Torbay Hospital, Torquay
Lead Sponsor
Collaborators (1)
Fortrea
INDUSTRY
Exact Sciences Corporation
INDUSTRY